The Company was able to export naturally derived psilocybin to their California-based Supply Partner, Mycrodose Therapeutics late last week. VANCOUVER, BC, Dec. 13, 2021 /CNW/ – Havn Life Sciences Inc.(CSE: HAVN) (OTC: HAVLF) (FSE: 5NP)(the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential active…
